A method for the ultramicro-measurement of human growth hormone (HGH) in plasma based on the solid-phase radioimmunoassay (RIA) using antibody-coated disposable microtiter trays was described. This method is simple, rapid and inexpensive,and particularly useful for ultramicro-measurement of plasma HGH levels in large numbers of plasma samples. The lower limit of sensitivity for purified HGH was 25pg/ml (P < 0.05). The precision of the measurement of HGH in plasma has been calculated, and the quantitative sensitivity of the method derived from the results given by its routine use was 56
plasma based on the solid-phase radioimmunoassay (RIA) using antibody-coated disposable microtiter trays was described. This method is simple, rapid and inexpensive,and particularly useful for ultramicro-measurement of plasma HGH levels in large numbers of plasma samples. The lower limit of sensitivity for purified HGH was 25pg/ml (P < 0.05). The precision of the measurement of HGH in plasma has been calculated, and the quantitative sensitivity of the method derived from the results given by its routine use was 56.8pg/ml (P<0.05). The HGH level of normal pooled plasma in 10 replicates was 1,515pg/ml The method of radioimmunoassay (RIA) developed by Yalow and Berson (1960) for the assay of human insulin had been soon applied to human growth hormone (HGH) (Utiger et al., 1962; Hunter and Greenwood, 1962; Glick et al., 1963) . During the past 10 years various modifications of radioimmunological methods were applied to the detection and assay of HGH in plasma. All forms of RIA used at present include a procedure to separate antibody-bound and free tracer hormone when equilibrium is reached in the incubation mixture. The conventional procedures of RIA have utilized a wide variety of techniques for the separation of bound and free tracer hormone, such as a second antibody, chromatoelectrophoresis, solvent fractionation, salt precipitation, or adsorption to charcoal.
The technique of solid-phase RIA was originally developed by Catt et al.(1966) for the assay of HGH in plasma. The solid-phase RIA allows rapid removal of the free radioactive tracer antigen only by washing of the solid-phase with water on completion of the immune reaction.
The present paper describes the development and application of the method for the ultramicro-measurement of HGH in plasma, based on the solid-phase RIA by using antibody-coated disposable microtiter trays. By further reduction in the amount of antibody with corresponding increase in the period of incubation, greater sensitivity has been achieved. This method has adequate sensitivity and precision for routine ultramicro-measurements of plasma HGH concentration, and is relatively simple to perform. By using this method, an attempt was made to differentiate patients with hypopituitarism from normal subjects on single basal plasma samples, although it had been hitherto generally accepted that determination of basal plasma HGH levels had not been of much value in the diagnosis of hypopituitarism Hunter and Greenwood, 1964a) .
Materials and Methods
Disposable microtiter tray Disposable microtiter trays (S-MRC 96, Linbro Chemical, New Haven, Connecticut, U.S.A.) were immersed in 70% ethanol for 10 min and washed out thoroughly with distilled water, and then used for assay.
Antiserum
The rabbit antiserum to HGH were kindly supplied by Dainabot Radioisotope Lab., Ltd., Japan. In ordinary solid-phase or double-antibody RIA, the optimal dilution of this antiserum was 1: 20,000. In this assay, aliquots of antiserum were diluted 1: 80,000 in 0.05 M phosphate buffer, pH 7.5, without containing bovine serum albumin.
109 mCi/mg was obtained from Dainabot Radioisotope Lab., Ltd., Japan which was made up in 0.1 M borate buffer, pH 8.6, containing 0.5% bovine serum albumin.
HGH reference preparation Human growth hormone for standards (NIH-GH-HS 1147) was prepered immediately before each assay as solutions containing 0, 10, 25, 50, 100, 250, 500, 1,000, 2,500, 5,000, 10,000 and 20,000pg/ml in 95 horse serum.
Assay procedure
The cups of a disposable microtiter tray were suppress completely HGH secretion in normal subjects.
Discussion
The technique of solid-phase radioimmunoassay (RIA) was originally developed for the measurement of HGH in plasma (Catt et al., 1966 (Catt et al., , 1967 . This simple and sensitive procedure was soon applied to the measurement of other peptide hormones namely human placental lactogen (Catt et al., 1967) , luteinizing hormone (Catt et al., 1968) , insulin (Colt et al., 1971) and prolactin (Fell et al., 1972) . The solid-phase materials had been prepared in the form of powder (Catt et al., 1966) , small discs (Catt et al., 1968; Catt, 1969) and tubes (Catt et al., 1967; Colt et al., 1971;  normal males (N=13) normal females (N=13) Fig. 4 . Plasma HGH concentrations during a standard oral glucose tolerance test (50 gm) in normal subjects. Fell et al., 1972) . The antibody-coated disposable microtiter tray method (Takeda et al., 1972; Nagayama et al., 1972; Ogawa et al., 1973; Furuno et al., 1973 ) is more simple and more inexpensive than the tube method. Although various customary RIA methods can be used as a routine on provocative tests, it would seem that further increase in sensitivity is desirable. Without the statistical evaluation, Catt et al.(1966) reported that the sensitivity of the powder form solid-phase method for plasma HGH estimation was always 0.4ng/ml or less, frequently under 0.1ng/ml. The results of present study demonstrate that greater sensitivity has been achieved in modification of the microtiter tray method by further reduction in the amount of antibody with corresponding increase in the period of incubation. The lower limit of quantitative sensitivity calculated from the precision of this solid-phase ultramicrodetermination method (`this method') during routine use has been taken as 56.8pg/ml rather than that calculated from the sensitivity of the standard curve, i.e. 25pg/ml. The discrepancy between the lower limit of quantitative sensitivity calculated from the routine use and that from the standard curve had been also reported by Hunter and Greenwood (1964a) , and they described that this differentiation suggested that measurement of HGH in plasma had been subject to a greater degree of imprecision than its measurement in pure solution or that there had been some degree of nonspecificity detectable at the lower limit of the method, or both. Anyway, 'this method' is thus extremely convenient for the ultramicro-measurement of HGH.
Up to this time, it had been generally accepted that determination of basal plasma HGH levels had not been of much value in the diagnosis of hypothalamic or pituitary hypofunction, because in many normal subjects these levels had been below the sensitivity of available assays Hunter and Greenwood, 1964a; Okada, 1970) . Further,
